文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

特利加压素联合去甲肾上腺素治疗脓毒性休克:系统评价

TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.
PubMed 文献 · Shock · 2023-08-07
一句话结论系统评价提示,早期联合去甲肾上腺素与特利加压素可能减少去甲肾上腺素用量、改善肾灌注和微循环,但外周缺血风险升高。

该研究系统检索PubMed、Cochrane、Embase、ScienceDirect和MEDLINE五个数据库截至2023年5月22日的文献,纳入7项随机对照试验,分析特利加压素(TP)联合去甲肾上腺素(NE)治疗成人脓毒性休克的效果。结果显示,联合治疗可能带来获益,并改善心输出量和中心静脉压;但存在包括外周缺血风险升高在内的风险与潜在不良事件。结论认为,现有证据支持早期联合NE与TP可能减少NE所需剂量、增强肾灌注、改善微循环。

要点

  • 纳入7项随机对照试验,评估特利加压素联合去甲肾上腺素治疗成人脓毒性休克。
  • 联合治疗可能带来获益,并改善心输出量和中心静脉压。
  • 需注意风险与潜在不良事件,包括外周缺血风险升高。
  • 作者认为早期联合NE与TP可能减少NE所需剂量、增强肾灌注、改善微循环。

适用人群与场景

  • 成人脓毒性休克患者(纳入随机对照试验的人群)。

红旗征与不能漏的情况

  • 联合治疗存在外周缺血风险升高,需警惕。

研究设计与关键结果

  • 系统检索PubMed、Cochrane、Embase、ScienceDirect和MEDLINE五个数据库,检索截至2023年5月22日,纳入7项随机对照试验。
  • 特利加压素联合去甲肾上腺素治疗成人脓毒性休克可能带来获益。
  • 联合治疗改善心输出量和中心静脉压;但存在风险与潜在不良事件,包括外周缺血风险升高。

证据类型、等级与局限

  • 证据类型:系统评价,纳入7项随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期联合去甲肾上腺素与特利加压素可能减少去甲肾上腺素所需剂量、增强肾灌注、改善脓毒性休克患者的微循环。
  • 联合治疗需注意外周缺血风险升高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: The objective of this study was to provide an in-depth analysis of the advantages and potential research directions concerning the utilization of terlipressin (TP) in combination with norepinephrine (NE) for the management of septic shock. Methods: A systematic search was conducted across five major electronic databases, namely, PubMed, Cochrane, Embase, ScienceDirect, and MEDLINE, using the Boolean method. The search encompassed articles published until May 22, 2023. Randomized controlled trials investigating the efficacy of TP combined with NE in the treatment of patients with septic shock were considered for inclusion. Results: A total of seven trials met the inclusion criteria. The combination therapy of TP and NE exhibited potential benefits in the treatment of adult patients suffering from septic shock. Furthermore, the concurrent administration of TP with NE demonstrated improvements in cardiac output and central venous pressure. However, it is important to acknowledge the presence of certain risks and potential adverse events, including an elevated risk of peripheral ischemia. Conclusions: The available evidence supports the notion that early combination therapy involving NE and TP holds promise in terms of reducing the required dosage of NE, enhancing renal perfusion, and improving microcirculation in patients diagnosed with septic shock.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Mao F, Liang D, Tang Z, et al. TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW. Shock. 2023. PMID: 37548701. doi:10.1097/SHK.0000000000002204

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。